Abstract
The proliferation and differentiation of bone marrow stem cell populations requires a balance between the need to meet the production of mature myeloid cells and the necessity of ensuring the retention of a population of self-renewing stem cells. This requires that the stem cell pool is protected from exhaustion by excessive differentiation pressure, providing a constant pool or reserve of stem cells throughout life. A number of models have been provided to explain this phenomenon. The stochastic model of Till and McCulloch (1980) envisages hematopoiesis engendered randomly (HER), whereas the deterministic model of Trentin (1970) envisaged the role of a hematopoietic inductive microenvironment (HIM). The current status of understanding of stem cell regulation requires a compromise between these two extreme views, in which stochastic events occur with a probability that can be modulated by external influences — a “loaded dice” concept. It is in this latter respect that hematopoietic growth factors may play a critical role.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abboud M, Moore MAS (1988) Recombinant human IL-3 is a basophil/mast cell growth factor (Abstr 123). Exp Hematol 16: 489
Aglietta M, Piacibello W, Sanavio F, Stacchini A, Apra F, Schena M, Mossetti C, Carnio F, Calgiras-Cappio F, Gavosto F (1989) Kinetics of human hemopoietic cells following in vivo administration of grnaulocyte-macrophage colony stimulating factor (GM-CSF). J Clin Invest (in press)
Antin JH, Smith BR, Holmes W, Rosenthal DS (1988) Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood 72: 705–713
Antman KS, Griffin JD, Elias A, Socinsky MA, Ryan L, Cannistra SA, Oette D, Whitley M, Frei E, Schnipper LE (1988) Effect of recombinant human granulocyte- macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 319: 593–598
Bagby GC, McCall E, Layman DL (1983) Regulation of colony stimulating activity production. Interactions of fibroblasts, mononuclear phagocytes and lactoferrin. J Clin Invest 71: 340–349
Bagby GC, Dinarello CA, Wallace P (1986) Interleukin 1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells. J Clin Invest 78: 1316–1325
Bertoncello I, Hodgson GS, Bradley TR (1988) Multiparameter analysis of transplantable hemopoietic stem cells. II. Stem cells of long-term bone marrow-reconstituted recipients. Exp Hematol 16: 245–249
Beutler B, Cerami A (1986) Cachectin and TNF as two sides of the same biological coin. Nature 320:584 Blazer
BR, Widmer MB, Soderling CCB, Gillis S, Vallera DA (1988) Enhanced survival but reduced engraftment in murine recipients of recombinant granulo-cyte/macrophage colony-stimulating factor following transplantation of T-cell- depleted histoincompatible bone marrow. Blood 72: 1148–1154
Bonilla MA, Gillio AP, Potter GK, O’Reilly RJ, Souza LM, Welte K (1987) Effects of recombinant human G-CSF and GM-CSF on cytopenias associated with repeated cycles of chemotherapy in primates. Blood [Suppl 1] 70: 130a
Bonilla MA, Gillio AP, Ruggiero M, Kernan NA, Brochstein JA, Fumagalli L, Bordig- non C, Vincent M, Welte K, Souza LM, O’Reilly RJ (1988) Correction of neutropenia in patients with congenital agranulocytosis with recombinant human granulocyte colony stimulating factor in vivo (Abstr 243). Exp Hematol 16: 520
Bradley TR, Hodgson GS, Bertoncello I (1982) Characteristics of primitive macro-phage progenitor cells with high proliferative potential: relationship to cells with marrow repopulating ability in 5-fluorouracil treated mouse bone marrow. In: Baum SJ, Ledney GD, van Bekkum DW (eds) Experimental hematology today. Springer, Berlin Heidelberg New York, pp 285–289
Brandt SJ, Peters WP, Atwater SK, Kurtzberg J, Borowitz MJ, Jones RB, Shpall EJ, Bast RC, Gilbert CJ, Oette DH (1988) Effect of recombinant human granulocyte- macrophage colony-stimulating factor on hematopoietic reconstitution after high- dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 318: 869–876
Bronchud MH, Scarffe JH, Thatcher N, Crowther D, Souza LM, Alton NK, Testa NG, Dexter TM (1987) Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 56: 809–813
Bronchud MH, Potter MR, Morgenstern G, Blasco MJ, Scarffe JH, Thatcher N, Crowther D, Souza LM, Alton NK, Testa NG, Dexter TM (1988) In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients. Br J Cancer 58: 64–69
Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S (1988) Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 16: 594–602
Campbell AD, Wicha MS, Long M (1985) Extracellular matrix promotes the growth and differentiation of murine hematopoietic cells in vitro. J Clin Invest 75: 2085–2090
Campbell AD, Long MW, Wicha MS (1987) Haemonectin, a bone marrow adhesion protein specific for cells of granulocyte lineage. Nature 329: 744–746
Champlin RE, Nimer SD, Oette D, Golde DW (1988) Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment for aplastic anemia (AA) or agranulocytosis (Abstr 238). Exp Hematol 16: 519
Chiu C-P, Moulds C, Coffman RL, Rennick D, Lee F (1988) Multiple biological activities are expressed by a mouse interleukin-6 cDNA clone isolated from bone marrow stromal cells. Proc Natl Acad Sei USA 85: 7099–7103
Daniels E (1988) Preliminary observations of the direct effects of interleukin-3 (IL-3) on mouse fetal hemopoiesis in vivo (Abstr 207). Exp Hematol 16: 511
Devereux S, Linch DC, Campos-Costa D, Spittle MF, Jelliffe AM (1987) Transient leukopenia induced by granulocyte-macrophage colony-stimulating factor. Lancet 2: 1523
Dexter TM (1987) Commentary: growth factors involved in haemopoiesis. J Cell Sei 88: 1–6
Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA, O’Connor JV (1986) Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1. J Exp Med 163: 1433–1439
Donahue RE, Wang EA, Stone S (1986) Stimulation of haemopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature 321: 872–874
Donahue RE, Sechra J, Metzger M, Lefebore D, Rock D, Carbone S, Nathan DG, Garnick M, Sehgal PK, Laston D, LaVillie E, McCoy J, Schendel PF, Norton C, Turner K, Yang Y-C, Clark SC (1988) Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science 241: 1820–1823
Dukes PP, Zsebo KM, Ma A, Polk C (1988) IL-1 affects the cell cycle state of day-12 CFU-s in marrow cell cultures (Abstr 49). Exp Hematol 16: 471
Dunn CDR, Jones JB, Lange RD, Wright EG, Moore MAS (1982) Production of presumptive humoral haematopoietic regulators in canine cyclic haematopoiesis. Cell Tissue Kinet 15: 1–10
Eaves CJ, Cashman JD, Eaves AC (1987) Selective and reversible inhibition of very primitive hemopoietic cells by tumor growth factor beta (TGF-ß). Blood [Suppl 1] 70: 171a
Enokihara H, Furusawa S, Kajitani H, Hamaguchi H, Saito K, Fukuda T, Shishido H (1988) Interleukin 2 stimulates T-cells from patients with eosinophilia to produce CFU-Eo growth stimulating factor. Br J Haematol 69: 431–436
Fibbe WE, van Damme J, Billiau A (1986) Interleukin-1 (22-K factor) induces release of granulocyte-macrophage colony-stimulating activity from human mononuclear phagocytes. Blood 68: 1316–1322
Fibbe WE, Damme J, Billiau A, Goselink HM, Voogt PJ, Eeden G, Ralph P, Altrock BW, Falkenburg JHF (1988) Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factor. Blood 71: 430–435
Gabrilove JL, Welte K, Harris P, Platzer E, Lu L, Levi E, Mertelsmann R, Moore MAS (1986) Pluripoietin alpha: a second human hematopoietic colony-stimulating factor produced by the human bladder carcinoma cell line 5637. Proc Natl Acad Sci USA 83: 2478–2482
Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MAS, Clarkson B, Oettgen HF, Alton K, Welte K, Souza L (1988) Effect of granulocyte colony-stimulting factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318: 1414–1422
Ganser A, Ottmann OG, Volkers B, Walther F, Becher R, Bergmann L, Hoelzer D (1988) Treatment with recombinant human granulocyte-macrophage colony- stimulating factor (rhGM-CSF) in patients with myelodysplasia syndromes (MDS) (Abstr 241). Exp Hematol 16: 520
Gascan H, Godard A, Praloran V, Naulet J, Moreau JF, Jacques Y, Soulillou JP (1989) Characterization of hilda/leukemia inhibitory factor secreted by human tumor cell lines. J Immunol (in press)
Gasparetto C, Laver J, Abboud M, Gillid A, Smith C, O’Reilly RJ, Moore MAS (1989) Effects of IL-1 on hematopoietic progenitors: evidence of stimulatory and in¬hibitory activities in a primate model. Blood . 74: 547–550
Gascon P, Scala G, Young N (1987) Interleukin 1 in hyper- and hypoproliferative bone marrow diseases: monocyte production in myelofibrosis and aplastic anemia. Blood [Suppl 1] 70: 135a
Gasson JC, Weisbart RH, Kaufman SE, Clark SC, Hewick RM, Wong GG, Golde DW (1984) Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. Science 226: 1339
Godard A, Gascan H, Naulet J, Peyrat M-A, Jacques Y, Soulillou J-P, Moreau J-F (1988) Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. Blood 71: 1618–1623
Gordon MY, Hibbin JA, Dowding C, Gordon-Smith EC, Goldman JM (1985) Separation of human blast progenitors from granulocytic, erythroid, megakaryocytic, and mixed colony-forming cells by “panning” on cultured marrow-derived stromal layers. Exp Hematol 13: 937–940
Gordon MY, Riley GP, Watt SM, Greaves MF ( 1987 a) Compartmentalization of a hematopoietic growth factor ( GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 326: 403–405
Gordon MY, Riley GP, Watt SM, Greaves MF ( 1987 a) Compartmentalization of a hematopoietic growth factor ( GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 130: 150–156
Gordon MY, Bearpark AD, Clarke D, Healy LE (1988) Matrix glycoproteins may locally regulate the relative concentrations of different haemopoietic growth factors (Abstr 16). Exp Hematol 16: 416
Gordon-Smith EC, Malkovska V, Myint AA, Gibson F, Milne A (1988) Growth factors and lymphokines in aplastic anaemia (Abstr 27). Exp Hematol 16: 419
Gough NM, Gearing DP, King TA, Willson DJ, Hilton DJ, Nicola NA, Metealf D (1988) Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukemia-inhibiting factor. Proc Natl Acad Sei USA 85: 2623–2628
Griffin JD (1988) Role of colony stimulating factors in the biology of leukemia (Abstr 20). Exp Hematol 16: 417
Groopman JE, Mitsuyasu RT, DeLeo MJ, Oette DH, Golde DW (1987) Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med 317: 593–598
Hamaguchi Y, Kanakura Y, Fujita J, Takeda S-I, Nakano T, Tauri S, Honjo T, Kitamura Y (1987) Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells. J Exp Med 165: 268–273
Hammond WP, Miller JE, McCall E (1988) Abnormal GM-CSF generation by lymphocytes in patients with cyclic hematopoiesis. Exp Hematol 16: 389–393
Herrmann F, Schulz G, Lindemann A, Gerhards U, Oster W, Mertelsmann R (1987) A phase I clinical trial of recombinant human granulocyte-macrophage colony stimulating factor (rh GM-CSF) in cancer patients: initial results. Blood [Suppl 1] 70: 230a
Herrmann F, Oster W, Meuer SC, Lindemann A, Mertelsmann RH (1988) Interleukin 1 stimulates T lymphocytes to produce granulocyte-monocyte colony-stimulating factor. J Clin Invest 81: 1415–1418
Hoelzer D, Ganser A, Volkers B, Greher J, Walther F (1988) In vitro and in vivo action of recombinant human GM-CSF in patients with myelodysplastic syndrome. Blood Cells 14: 551–559
Hultner L, Welle M, Szots H, Dormer P (1988) Expression of IL-6 mRNA and secretion of IL-6 in mouse bone marrow-derived IL-3-dependent mast cell lines and tumorigenic sublines (Abstr 187). Exp Hematol 16: 506
Ihle JN, Keller J, Oroszan S, Henderson L, Copeland TD, Finch F, Prostowsky MD, Goldwasser E, Schräder JW, Palasynski E, Dy M, Label B (1983) Biological properties of homogeneous interleukin-3.1. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, P cell-stimulating factor activity, colony stimulating factor activity and histamine producing cell-stimulating activity. J Immunol 131: 282–287
Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M (1987) Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 84: 9035–9039
Iscove NN, Fagg B, Keller G (1988) A soluble activity from adherent marrow cells cooperates with IL-3 in stimulating growth of pluripotential hematopoietic precursors. Blood 71: 953–957
Jakubowski AA, Souza L, Kelly F, Fain K, Budman D, Clarkson B, Bonilla MA, Moore MAS, Gabrilove JL (1989) Effects of human granulocyte colony stimulating factor on a patient with idiopathic neutropenia. N Engl J Med 320: 38–42
Jubinsky PT, Stanley ER (1985) Purification of hemopoietin-1: a multilineage hemopoietic growth factor. Proc Natl Acad Sei USA 82: 2764–2769
Kaushansky K, Broudy VC, Harlan JM, Asamson JW (1987) Tumor necrosis factor (TNF-a) and lymphotoxin (TNF-ß) stimulate the production of GM-CSF, M-CSF, and IL-1 production in vivo (Abstr 552). Blood [Suppl 1] 70: 174a
Keller JR, Mantel C, Sing GK, Ellingsworth LR, Ruscetti SK, Ruscetti FW (1988) Transforming growth factor ßl selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J Exp Med 168: 737–750
Klebanoff SJ, Vadas MA, Harlan JM, Sparks LJ, Gamble JR, Agosti JM, Waltersdorph AM (1986) Stimulation of neutrophils by tumor necrosis factor. J Immunol 36: 4220
Kleinerman ES, Knowles RD, Lachman LB, Gutterman JU (1988) Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration. Cancer Res 48: 2604–2609
Kobayashi Y, Okabe T, Urabe A, Takaku F (1988) Effect of recombinant human granulocyte colony stimulating factor (rHuG-CSF) on bone marrow failure cases (Abstr 223). Exp Hematol 16: 515
Koeffler HP, Gasson J, Ranyard J, Souza L, Shepard M, Munker R (1987) Recombinant human TNF alpha stimulates production of granulocyte colony-stimulating factor. Blood 70: 55
Koike K, Ihle JN, Ogawa M (1986) Declining sensitivity to interleukin 3 of murine multipotential hemopoietic progenitors during their development: application to a culture system that favors blast cell colony formation. J Clin Invest 77: 894–899
Koike K, Nakahata T, Takagi M, Kobayashi T, Ishiguro A, Tsuji K, Naganuma K, Okano A, Akiyama Y, Akabane T (1988) Synergism of BSF-2/interleukin 6 and interleukin 3 on development of multipotential hemopoietic progenitors in serum-free culture. J Exp Med 168: 879–890
Krumwieh D, Seiler FR, Welte K (1988) Changes of hematopoiesis in cynomolgus monkeys after application of human colony-stimulating factors (Abstr 364). Exp Hematol 16: 551
Kurland JI, Peius LM, Ralph P, Bockman RS, Moore MAS (1979) Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role for colony- stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation. Proc Natl Acad Sei USA 76: 2326–2330
Laver J, Abboud M, Warren D, Moore MAS (1988 a) Radioprotective effects of interleukin 1 on human hematopoietic progenitors (Abstr 96). Exp Hematol 16: 482
Laver J, Castro-Malaspina H, Kernan NA, Levick J, Evans RL, O’Reilly RJ, Moore MAS (1988 b) In vitro interferon-gamma production by cultured T-cells in severe aplastic anaemia: correlation with granulomonopoietic inhibition in patients who respond to anti-thymocyte globulin. Br J Haematol 69:545–550
Leary AG, Ikebuchi K, Hirai Y, Wong GG, Yang Y-C, Clark SC, Ogawa M (1988) Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-la. Blood 71: 1759–1763
Lindemann A, Riedel D, Oster W, Meuer SC, Blohm D, Mertelsmann RH, Herrmann F (1988) Granulocyte/macrophage colony-stimulating factor induces interleukin 1 production by human polymorphonuclear neutrophils. J Immunol 140: 837–839
Lopez AF, Williamson DJ, Gamble GR, Begley CG, Harlan JM, Klebanoff SJ, Waltersdorph A, Wong G, Clark SC, Vadas MA (1986) Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest 78: 1220–1228
Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young L, Vadas MA (1988) Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 167: 219–224
Lothrop CD, Warren DJ, Souza LM, Jones JB, Moore MAS (1988) Correction of canine cyclic hematopoiesis with recombinant human granulocyte colony stimulating factor. Blood 72: 1324–1328
Lovhaug D, Peius LM, Nordlie EM, Boyum A, Moore MAS (1986) Monocyte conditioned medium and interleukin 1 induce granulocyte-macrophage colony stimulating factor production in the adherent cell layer of murine bone marrow cultures. Exp Hematol 14: 1037–1042
Masaoka T, Motoyoshi K, Takaku F, Moriyama Y, Ohira M, Kato S, Dohi H, Horiuchi A (1988) Human urinary macrophage-colony stimulating factor for bone marrow transplantation (Abstr 42). Exp Hematol 16:469
McNiece IK, Stewart FM, Deacon DM, Quesenberry PJ (1988) Synergistic interactions between hematopoietic growth factors as detected by in vitro mouse bone marrow colony formation. Exp Hematol 16: 383–388
Mertelsmann R, Cozman D (1988) Colony stimulating factors in vivo and in vitro. Immunol Today 9:97–98
Metcalf D (1989) Haematopoietic growth factors I. Lancet 126: 825–827
Moore MAS ( 1987 a) G-CSF as a differentiation-inducing agent in normal and leukemic myelopoiesis. In: Aarbakke J, Chiang P, Koeffler HP (eds) The biology and pharmacology of tumor cell differentiation. Humana, Clifton, pp 29–49
Moore MAS ( 1987 b) Growth and maturation factors in leukemia. In: Oldham RK (ed) Principles of cancer biotherapy. Raven, New York, pp 399–446
Moore MAS ( 1987 c) Interactions between hematopoietic growth factors: the clinical role of combination biotherapy. In: Neth R, Gallo RC, Greaves MF, Kabisch H (eds) Modern trends in human leukemia 7. Springer, Berlin Heidelberg New York
Moore MAS ( 1988 a) The use of hematopoietic growth and differentiation factors for bone marrow stimulation. In: Devita VT, Hellman S, Rosenberg SA (eds) Important advances in oncology 1988. Lippincott, Philadelphia, pp 31–54
Moore MAS ( 1988 b) Interleukin 3: an overview. In: Schräder J (ed) Lymphokines, vol 15. Academic, New York, pp 219–280
Moore MAS (1988 c) Combination biotherapy: synergistic, additive and concatenate interactions between CSFs and interleukins in hematopoiesis. In: Fortner JG, Rhoads JE (eds) Accomplishments in cancer research 1987. Lippincott, Philadelphia, pp 335–350
Moore MAS, Sheridan AP (1979) Pluripotential stem cell replication in continuous human, prosimian, and murine bone marrow culture. Blood Cells 5: 297–311
Moore MAS, Warren DJ (1987) Interleukin-1 and G-CSF synergism: in vivo stimulation of stem cell recovery and hematopoietic regeneration following 5-fluorouracil treatment in mice. Proc Natl Acad Sei USA 84: 7134–7138
Moore MAS, Warren DJ (1989) Combination biotherapy in vivo and in vitro with IL-1, IL-3, IL-5, G-CSF, and GM-CSF. In: Groopman J, Evans C, Golde D (eds) Moore MAS, Warren DJ pp 77–88 ( UCLA symposia on molecular and cellular biology, new series )
Moore MAS, Spitzer G, Metealf D, Penington DG (1974) Monocyte production of colony stimulating factor in familial cyclic neutropenia. Br J Haematol 27: 47–55
Moore MAS, Sheridan APC, Allen TD, Dexter TM (1979) Prolonged hematopoiesis in a primate bone marrow culture system: characteristics of stem cell production and the hematopoietic microenvironment. Blood 54: 775–793
Moore MAS, Broxmeyer HE, Sheridan APC, Meyers PA, Jacobsen N, Winchester RJ (1980) Continuous human bone marrow culture: la antigen characterization of probable human pluripotential stem cells. Blood 55: 682–690
Moore MAS, Warren DJ, Souza L (1987 a) Synergistic interaction between interleukin- 1 and CSFs in hematopoiesis. In: Gale RP, Golde DW (eds) Recent advances in leukemia and lymphoma. Liss, New York, pp 445–456 (UCLA symposium on leukemia)
Moore MAS, Welte K, Gabrilove J, Souza LM ( 1987 b) Biological activities of recombinant human granulocyte-colony stimulating factor (rhG-CSF) and tumor necrosis factor: in vivo and in vitro analysis. In: Neth R, Gallo RC, Greaves MF, Kabisch H (eds) Modern trends in human leukemia 7. Springer, Berlin Heidelberg New York, pp 210–220
Moore RN, Oppenheim JJ, Farrar JJ (1986) Production of lymphocyte-activated with colony-stimulating factors. J Immunol 125: 1302–1310
Moreau JF, Bonneville M, Godard A, Gascan H, Gruart V, Moore MA, Soulillou JP (1987) Characterization of a factor produced by human T cell clones exhibiting eosinophil-activating and burst-promoting activities. J Immunol 138: 3844–3849
Morstyn G, Souza LM, Keech J, Sheridan W, Campbell L, Alton NK, Green M, Metealf D, Fox R (1988) Effect of granulocyte colony stimulating factor on neutrophenia induced by cytotoxic chemotherapy. Lancet 1: 667–672
Motoyoshi K, Takaku F (1988) Accelerated recovery from thrombocytopenia and neutropenia after anticancer chemotherapy by consecutive intravenous infusions of human monocytic colony-stimulating factor (Abstr 237). Exp Hematol 16: 519
Munker R, Koeffler HP (1987) In vitro action of tumor necrosis factor on myeloid leukemia cells. Blood 69: 1102
Munker R, DiPersio J, Koeffler HP (1987) Tumor necrosis factor: receptors on hematopoietic cells. Blood 70: 1730
Nakahata T, Ogawa M (1982) Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renew and generate multi- potential hemopoietic colonies. Proc Natl Acad Sei USA 79: 3843–3848
Naparstek E, Ohana M, Kedar E, Slavin S (1988) Continuous intravenous administration of GM-CSF enhances hemopoietic and immune recovery in marrow transplantation in mice (Abstr 156). Exp Hematol 16: 498
Negrin RS, Haeuber DH, Nagler A, Souza LM, Greenberg PL (1988) Treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor (Abstr 240). Exp Hematol 16: 519
Nemunaitis J, Singer JW, Buckner CD, Hill R, Storb R, Thomas ED, Appelbaum FR (1988) Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Blood 72: 834–836
Neta R, Oppenheim JJ, Douches SD (1988) Interdependence of the radioprotective effects of human recombinant interleukin-la, tumor necrosis factor a, granulocyte colony stimulating factor and murine recombinant granulocyte-macrophage colony stimulating factor. J Immunol 140: 108
Nissen C, Stern A, Jones TH, Schaedelin J (1988) European double blind randomized trial of GM-CSF in patients after transplantation of T-cell depleted bone marrow (Abstr 235). Exp Hematol 16: 518
Ohta M, Greenberger JS, Anklesaria P, Bassols A, Massague J (1987) Two forms of transforming growth factor-ß distinguished by multipotential haematopoietic progenitor cells. Nature 329: 539 - 541
Oppenheim JJ, Kovacs EJ, Matsushima K (1986) There is more than one interleukin 1. Immunol Today 7: 45–55
Oster W, Lindemann A, Horn S, Mertelsmann R, Herrmann F (1987) Tumor necrosis factor (TNF)-alpha but not TNF-beta induces secretion of colony stimulating factor for macrophages (CSF-1) by human lymphocytes. Blood 70: 1700
Ottmann OG, Peius LM (1988) Differential proliferative effects of transforming growth factor-ß on human hematopoietic progenitor cells. J Immunol 140: 2661–2665
Ottmann OG, Welte K, Souza LM, Moore MAS (1987) Proliferative effects of a recombinant human granulocyte-colony stimulating factors (rG-CSF) on highly enriched hematopoietic progenitor cells. In: Neth R, Gallo RC, Greaves MF, Kabisch H (eds) Modern trends in human leukemia 7. Springer, Berlin Heidelberg New York, pp 244–247
Patel VP, Lodish HF (1986) Loss of adhesion of murine erythroleukemia cells to fibronectin during erythroid differentiation. Science 224: 996–998
Peetre C, Gullberg U, Nilsson E, Olsson I (1988) Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hematopoietic cells in vitro. J Clin Invest 78: 1694
Peters WP, Stuart A, Affronti ML, Kim CS, Coleman RE (1988) Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans. Blood 72: 1310–1315
Platzer E, Welte K, Gabrilove JL, Lu L, Harris P, Mertelsmann R, Moore MAS (1985) Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells. J Exp Med 162: 1788–1801
Raghavachar A, Fleischer S, Frickhofen N, Heimpel H, Fleischer B (1987) T lymphocyte control of human eosinophilic granulopoiesis: clonal analysis in an idiopathic hypereosinophilic syndrome. J Immunol 139: 3753–3758
Roberts RA, Spooncer E, Parkinson EK, Lord BI, Allen TD, Dexter TM (1987) Metabolically inactive 3T3 cells can substitute for marrow stromal cells to promote the proliferation and development of multipotent haemopoietic stem cells. J Cell Physiol 132: 203–214
Roberts RA, Gallagher J, Spooncer E, Allen TD, Bloomfield F, Dexter TM (1988) Heparin sulfate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 332: 376–378
Rothenberg ME, Owen WF, Silberstein DS, Woods J, Soberman RJ, Austen FK, Stevens RL (1988) Human eosinophils have prolonged survival, enhanced functional properties and become hypodense when exposed to human interleukin 3. J Clin Invest 81: 1986–1992
Ruscetti FW, Sing G, Ruscetti SK, Ellingsworth LE, Keller JR (1988) The role of transforming growth factor-ß in the regulation of normal and leukemic hematopoiesis (Abstr 19). Exp Hematol 16: 417
Sanderson CJ, O’Garra A, Warren DJ, Klaus GGD (1986) Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4. Proc Natl Acad Sei USA 83: 437–441
Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA (1985) Activation of human polymorphonuclear neutrophil functions by interferon gamma and tumor necrosis factor. J Immunol 135: 2069–2076
Sieff CA, Tsai S, Faller DV (1987) Interleukin 1 induces cultured human endothelial cell production of granulocyte-macrophage colony-stimulating factor. J Clin Invest 78: 48–57
Slordal L, Warren DJ, Moore MAS (1989) Effect of recombinant murine tumor necrosis factor on hematopoietic reconstitution in sublethally irradiated mice. J Immunol 142: 833–835
Smith CA, Rennick DM (1986) Characterization of a murine lymphokine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell growth factor activity that synergizes with IL-3. Proc Natl Acad Sei USA 83: 1857–1861
Socinski MA, Cannistra SA, Sullivan R, Elias A, Antman K, Schnipper L, Griffin JD (1988) Granulocyte-macrophage colony-stimulating factor induces the expression of the CDllb surface adhesion molecule on human granulocytes in vivo. Blood 72: 691–697
Souza LM, Boone TC, Gabrilove JL, Lai PH, Zsebo KM, Murdock DC, Chazin VR, Bruszewski J, Lu H, Chen KK, Barendt J, Platzer E, Moore MAS, Mertelsmann R, Welte K (1986) Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 232: 61–65
Spooncer E, Gallagher JT, Krizsa F, Dexter TM (1983) The regulation of haemopoiesis in long term bone marrow cultures. IV. glycosaminoglycan synthesis and stimulation of haemopoiesis by beta-D-xylosides. J Cell Biol 96: 510–514
Spooncer E, Lord BI, Dexter TM (1985) Defective ability to self-renew in vitro of highly purified primitive haematopoietic cells. Nature 316: 62–64
Spooncer E, Heyworth CM, Dunn A, Dexter TM (1986) Self-renewal and differentiation of interleukin-3 dependent multipotent stem cells are modulated by stromal cells and serum factors. Differentiation 31: 111–118
Stanley ER, Bartocci A, Patinkin D, et al. (1986) Regulation of very primitive multipotent hemopoietic cells by hemopoietin-1. Cell 45: 667–671
Steffen M, Abboud M, Potter GK, Yung YP, Moore MAS (1989) Production of tumor necrosis factor by human mast cells. Immunology (in press)
Taylor K, Spitzer G, Jagannath S, Dicke K, Vincent M, Souza L (1988) rhG-CSF hastens granulocyte recovery in Hodgkin’s disease after high-dose chemotherapy and autologous bone marrow transplant (Abstr 3). Exp Hematol 16: 413
Tertian G, Yung YP, Guy-Grand D, Moore MAS (1981) Long term in vitro culture of murine mast cells I. Description of a growth factor dependent culture technique. J Immunol 127: 788–794
Teshima H, Shibata H, Hiraoka A, Nakamura H, Masaoka T, Takaku F (1988) Clinical effects of recombinant human granulocyte colony-stimulating factor (Abstr 244). Exp Hematol 16: 520
Till JE, McCulloch (1980) Haemopoietic stem cell differentiation. Biochim Biophys Acta 605: 431–459
Trentin JJ (1970) Influence of hematopoietic organ stroma (hematopoietic inductive microenvironment) on stem cell differentiation. In: Gordon A (ed) Regulation of hematopoiesis. Appleton-Century-Crofts, New York, pp 161–186
Vadhan-Raj S, Keating M, LeMaistre A, Hittelman WN, McCredie K, Trujillo JM, Broxmeyer HE, Henney C, Gutterman JU (1987) Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodys plastic syndromes. N Engl J Med 317: 1545–1552
Vadhan-Raj S, Buescher S, LeMaistre A, Ventura G, Lepe-Zuniga J, Broxmeyer HE, Gillis S, Gutterman JU (1988) Effects of recombinant human granulocyte- macrophage colony-stimulating factor in patients with aplastic anemia (Abstr 239). Exp Hematol 16: 519
Vellenga E, Rambaldi A, Ernst TJ, Ostapovicz D, Griffin JD (1988) Independent regulation of M-CSF gene expression in human monocytes. Blood 71: 1529–1532
Vogel SN, Douches SD, Kaufman EN, Neta R (1987) Induction of colony stimulating factor in vivo by recombinant interleukin la and recombinant tumor necrosis factor a. J Immunol 138: 2143–2148
Wang JM, Chen ZG, Colella S, Bonilla MA, Welte K, Bordignon C, Mantovani A (1988) Chemotactic activity of recombinant human granulocyte colony-stimulating factor. Blood 72: 1456–1460
Wankowicz Z, Megyeri P, Issekutz A (1988) Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of polymorphonuclear leukocyte migration during inflammation. J Leukocyte Biol 43: 349–356
Warren DJ, Moore MAS (1988) Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells. J Immunol 140: 94–99
Warren MK, Ralph P (1986) Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol 137: 2281–2285
Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R, Moore MAS (1985) Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci USA 82: 1526–1530
Welte K, Bonilla MA, Gillio AP, Boone TC, Potter GK, Gabrilove JL, Moore MAS, O’Reilly J, Souza LM (1987) Recombinant human granulocyte colony-stimulating factor: effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med 1645: 941–948
Welte K, Reiter A, Odenwald E, Muller W, Seidel J, Schulz G, Riehm H (1988) Initial results with granulocyte-macrophage colony stimulating factor in children with congenital agranulocytosis (Abstr 242). Exp Hematol 16: 520
Wong GG, Witek-Giannotti JS, Temple PA, Kriz R, Ferenz C, Hewick RM, Clark SC, Ikebuchi K, Ogawa M (1988) Stimulation of murine hemopoietic colony formation by human IL-6. J Immunol 140: 3040–3044
Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harada N, Tominaga A, Takatsu K (1988) Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 167: 43–56
Yung YP, Moore MAS (1982) Long-term in vitro culture of murine mast cells III. Discrimination of mast cell growth factor and granulocyte CSF. J Immunol 129: 1256–1261
Yung YP, Eger R, Teritian G, Moore MAS (1981) Long term in vitro culture of murine mast cells II. Purification of a mast cell growth factor and its dissociation from TCGF. J Immunol 127: 794–799
Zoumbos NC, Gascon P, Djeu JY, Young NS (1985) Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci USA 82: 188–192
Zucali JR, Broxmeyer H, Gross MA, Dinarello CA (1988) Recombinant human tumor necrosis factors alpha and beta stimulate fibroblasts to produce hemopoietic growth factors in vitro. J Immunol 140: 840–850
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Moore, M.A.S. (1990). Coordinate Actions of Hematopoietic Growth Factors in Stimulation of Bone Marrow Function. In: Sporn, M.B., Roberts, A.B. (eds) Peptide Growth Factors and Their Receptors II. Handbook of Experimental Pharmacology, vol 95 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74781-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-74781-6_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74783-0
Online ISBN: 978-3-642-74781-6
eBook Packages: Springer Book Archive